Why the study?
Doxorubicin administration is limited by adverse effects including testicular toxicity and male infertility, so researchers investigated whether nanocurcumin could mitigate this damage.
Does Nanocurcumin prevent Doxorubicin-induced testicular toxicity in male rats?
Does Nanocurcumin prevent Doxorubicin-induced testicular toxicity in male rats?
Nanocurcumin mitigates doxorubicin-induced testicular toxicity in a rat model by modulating oxidative stress and apoptotic pathways.
NCR may attenuate DOX testicular toxicity in preclinical models; leaves open clinical utility for fertility preservation during chemotherapy.
BACKGROUND: Doxorubicin (DOX) is a potent anti-cancer agent that is widely described in cancer treatment. However, its administration is often limited by its adverse effects, particularly its testicular toxicity, which can induce infertility in male patients. DOX-induced testicular damage is due to oxidative stress, apoptosis, and inflammation. Nanocurcumin (NCR) is a nano-formulated edition of curcumin with a higher therapeutic potential. NCR has demonstrated antioxidant and anti-inflammatory properties. METHODS: This study is designed to inspect the potential validity of NCR on DOX-induced testicular damage in male rats. We used thirty-two Wistar albino rats (150-200 g) and divided them into four groups. NCR (80 mg/kg/ dissolved in 1% CMC) was given orally by oral gavage for 14 days. A single dose of DOX (15 mg/kg) (i.p.) was injected on the 7th day of the experiment. RESULTS: DOX treatment reduced the sperm viability and motility rate, cellular antioxidants, and gonadal hormones; it led to higher levels of inflammatory mediators, necrosis, and sloughing in seminiferous tubules. Conversely, NCR treatment significantly alleviated these side effects by improving sperm count/motility and reducing sperm abnormalities. The testicular function recovery was likely driven by stimulating the cytoprotective SIRT1/NF-κB pathway, depressing the testicular level of oxidative indicators such as MDA, TNF-α, iNOS, IL-1β, and NO, and increasing levels of antioxidants such as GSH and SOD. In addition, NCR contradicted the apoptotic changes by downregulating the pro-apoptotic signals Bax and caspase-3, while inducing Bcl-2 upregulation. Moreover, NCR increased levels of gonadal hormones, attenuated histological abnormalities, and preserved testicular structure when compared with the DOX group. CONCLUSIONS: NCR treatment can effectively ameliorate DOX-induced testicular toxicity.
No takes yet. Share an insight, caveat, or question.
Alshuwayer et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: